跳至主要内容
临床试验/EUCTR2020-001817-20-DK
EUCTR2020-001817-20-DK进行中(未招募)1 期

Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation - POPULAR PAUSE TAVI trial

St. Antonius Hospital Nieuwegein, The Netherlands0 个研究点目标入组 858 人开始时间: 2022年5月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
858

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Planned transfemoral or transsubclavian TAVI procedure
  • Uses oral anti-coagulation at screening
  • Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 808

排除标准

  • Patients at high risk for thromboembolism for who interruption of oral anticoagulants is no option, i.e.:
  • -Mechanical heart valve
  • -Intracardiac thrombus
  • -< 3 months after venous thromboembolism
  • -< 6 months after TIA/stroke in patients with atrial fibrillation

研究者

发起方
St. Antonius Hospital Nieuwegein, The Netherlands

相似试验